| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Plenful is a healthcare automation software company that partners with healthcare organizations to increase revenue, decrease costs, and optimize workflows through their no code automation and AI-enabled platform.
ChangeEngine. Discover, design, and send contextual communications during the moments that matter most throughout the employee journey.
Earley Information Science builds the information architecture that powers unrivaled customer experience, smart eCommerce, and accelerated business decisions.
Katalon is a powerful solution that helps you automate Web, API, Mobile, and Desktop apps — with smart analytics and CI/CD integrations. Get started now!